Clincosm LogoSign in Get a demo

Recurrent Plasma Cell Myeloma

Showing NaN - NaN of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Plasma Cell Leukemia
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Hematopoietic and Lymphoid Cell Tumor, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +13 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 8, 2022

Recurrent Plasma Cell Myeloma Trial in Houston (Daratumumab)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Daratumumab
  • Houston, Texas
    M D Anderson Cancer Center
Dec 22, 2021

Frequency of Cachexia in Ambulatory Cancer Patients and

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Oct 1, 2021

Multiple Myeloma-Light Chain Only, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (drug,

Terminated
Has Results
  • Multiple Myeloma-Light Chain Only
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Bendamustine Hydrochloride, Carfilzomib,

Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Bendamustine Hydrochloride
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 7, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Dexamethasone, Lenalidomide, Thalidomide)

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2020

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (Carfilzomib, Dexamethasone, Laboratory

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Fairbanks, Alaska
  • +484 more
Apr 3, 2020

Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Carfilzomib, Filanesib,

Completed
  • Plasma Cell Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 12, 2019

Recurrent Plasma Cell Myeloma Trial in United States (Bortezomib, Dexamethasone, Dinaciclib)

Completed
  • Recurrent Plasma Cell Myeloma
  • Scottsdale, Arizona
  • +5 more
May 10, 2018